Healthcare -
Biotechnology - NASDAQ - US
$ 2.12
-2.3 %
$ 19.6 M
Market Cap
-0.34
P/E
SABS - LONG-TERM DEBT
Long-term Debt SABS - SAB Biotherapeutics, Inc.
4.05 M
LAST VALUE
-13.48%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR